Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Dotta

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Il Policlinico. Sezione Medica|March 1, 1971
[Sobrerol for the treatment of chronic obstructive bronchopneumopathies (clinical and functional observations)]F Dotta, A Bianchi
Clinical Immunology and Immunopathology|January 1, 1989
Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destructionF Dotta, G S Eisenbarth
Diabetes/Metabolism Reviews|May 30, 1998
Beta-cell autoimmunity 1998U Di Mario, F Dotta
Annali Di Igiene : Medicina Preventiva E Di Comunita|May 1, 1992
Natural history and prediction of type 1 diabetesU Di Mario, F Dotta
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 1, 1996
Antigenic determinants in type 1 diabetes mellitus. Review articleF Dotta, U Di Mario
Diabetes/Metabolism Reviews|December 1, 1993
Modulation of antigen expression in relation to intervention strategies in type 1 diabetesU Di Mario, F Dotta
Transplantation Proceedings|February 22, 2011
MicroRNAs as new tools for exploring type 1 diabetes: relevance for immunomodulation and transplantation therapyG Sebastiani, F Vendrame, F Dotta
Minerva Medica|July 24, 2004
Markers of beta cell function in type 1 diabetes mellitusF Vendrame, A Zappaterreno, F Dotta
La Clinica Terapeutica|May 31, 1983
[Efficacy of mucotropic agents in the treatment of bronchial asthma. Preliminary study of 2-(alpha-thenoylthio)-propionylglycine]F Dotta, A Ciani, A Acone, et al.
Diabetes, Obesity & Metabolism|March 27, 2009
Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitusE Bosi, F Dotta, Y Jia, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Il Policlinico. Sezione Medica|March 1, 1971
[Sobrerol for the treatment of chronic obstructive bronchopneumopathies (clinical and functional observations)]F Dotta, A Bianchi
Clinical Immunology and Immunopathology|January 1, 1989
Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destructionF Dotta, G S Eisenbarth
Diabetes/Metabolism Reviews|May 30, 1998
Beta-cell autoimmunity 1998U Di Mario, F Dotta
Annali Di Igiene : Medicina Preventiva E Di Comunita|May 1, 1992
Natural history and prediction of type 1 diabetesU Di Mario, F Dotta
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 1, 1996
Antigenic determinants in type 1 diabetes mellitus. Review articleF Dotta, U Di Mario
Diabetes/Metabolism Reviews|December 1, 1993
Modulation of antigen expression in relation to intervention strategies in type 1 diabetesU Di Mario, F Dotta
Transplantation Proceedings|February 22, 2011
MicroRNAs as new tools for exploring type 1 diabetes: relevance for immunomodulation and transplantation therapyG Sebastiani, F Vendrame, F Dotta
Minerva Medica|July 24, 2004
Markers of beta cell function in type 1 diabetes mellitusF Vendrame, A Zappaterreno, F Dotta
La Clinica Terapeutica|May 31, 1983
[Efficacy of mucotropic agents in the treatment of bronchial asthma. Preliminary study of 2-(alpha-thenoylthio)-propionylglycine]F Dotta, A Ciani, A Acone, et al.
Diabetes, Obesity & Metabolism|March 27, 2009
Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitusE Bosi, F Dotta, Y Jia, et al.
Pageof 9